Immunologic rejection of the central graft after limbal allograft transplantation combined with penetrating keratoplasty. 2001

J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
Department of Ophthalmology, Tokyo Dental College, Chiba, Japan. jun@eyebank.or.jp

OBJECTIVE To study the incidence and prognosis of immunologic rejection of the central graft after limbal allograft transplantation (keratolimbal allograft transplantation [KLAT]) combined with penetrating keratoplasty (PKP). METHODS Endothelial rejection in central penetrating graft after simultaneous KLAT and PKP using the same donor cornea was retrospectively studied. Incidence, reversibility, prognosis, and changes in limbal grafts were examined. RESULTS Forty-five eyes underwent simultaneous PKP and KLAT. Endothelial rejection of the central graft was found in 16 eyes (35.6%). At last examination, 10 grafts (62.5%) restored clarity after immunosuppressive therapy. During rejection episodes, four eyes showed engorgement of vessels in limbal grafts, which existed before the episodes. Only one eye developed neovascularization with mild edema of the limbal grafts; however, no other limbal grafts showed abnormalities on biomicroscopy. No epithelial changes were noted, and 14 grafts (87.5%) were covered by corneal epithelium after the rejection. CONCLUSIONS Approximately one third of eyes had endothelial rejection in the central graft after simultaneous KLAT and PKP. Abnormalities suggestive of rejection in the limbal grafts were seldom observed in these eyes, suggesting that immunologic response was different in central and limbal grafts.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003316 Corneal Diseases Diseases of the cornea. Corneal Disease,Disease, Corneal,Diseases, Corneal
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
September 1997, Ophthalmic surgery and lasers,
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
January 1993, Ophthalmic surgery,
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
April 2002, American journal of ophthalmology,
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
November 2002, American journal of ophthalmology,
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
June 1991, American journal of ophthalmology,
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
September 2009, Oman journal of ophthalmology,
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
July 2013, Ophthalmology,
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
March 2005, Archives of ophthalmology (Chicago, Ill. : 1960),
J Shimazaki, and F Maruyama, and S Shimmura, and H Fujishima, and K Tsubota
July 2023, European journal of ophthalmology,
Copied contents to your clipboard!